Skip to main content
. 2021 Apr 1;138:104817. doi: 10.1016/j.jcv.2021.104817

Table 3.

Time to positivity of the eazyplex® SARS-CoV-2 for clinical samples.

Target Median threshold time, min (IQR)
N gene 12.5 (10.1−16)
ORF8 gene 14.25 (10.75−18)
Sample control (human DNA) 15.5 (12−18.75)
Inhibition control 8.25 (7.75−8.5)

IQR, interquartile range.